Patent details

EP1234031 Title: B7-H1, A NOVEL IMMUNOREGULATORY MOLECULE

Basic Information

Publication number:
EP1234031
PCT Application Number:
US2000032583
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009838210
PCT Publication Number:
WO2001039722
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
B7-H1, A NOVEL IMMUNOREGULATORY MOLECULE
French Title of Invention:
NOUVELLE MOLÉCULE IMMUNORÉGULATRICE B7-H1,
German Title of Invention:
B7-H1, EIN NEUARTIGES IMMUNREGULIERENDES MOLEKÜL
SPC Number:

Dates

Filing date:
30/11/2000
Grant date:
15/03/2017
EP Publication Date:
28/08/2002
PCT Publication Date:
07/06/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/03/2017
EP B1 Publication Date:
15/03/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
30/11/2017
Expiration date:
30/11/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/03/2017
 
 

Name:
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Address:
200 First Street S.W., Rochester, MN 55905, United States (US)

Inventor

Name:
CHEN, Lieping
Address:
United States (US)

Priority

1

Priority Number:
451291
Priority Date:
30/11/1999
Priority Country:
United States (US)

2

Priority Number:
649108
Priority Date:
28/08/2000
Priority Country:
United States (US)

Classification

IPC classification:
C07K 14/705; C07K 16/28; C07K 16/46;

Publication

European Patent Bulletin

1

Issue number:
201711
Publication date:
15/03/2017
Description:
Grant (B1)

2

Issue number:
201715
Publication date:
12/04/2017
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/03/2018 Outgoing Correspondence 1